Medical Economics September 11, 2023
Jeffrey Bendix

Legislation also provides more funding for community health centers and diabetes research

A bipartisan bill designed to increase health care price transparency and lower costs for prescription drugs and health care services was introduced September 8 by the chairs of three House of Representatives committees with jurisdiction over health care.

Dubbed the “Lower Costs, More Transparency Act” the bill would, among other provisions, require health insurers and pharmacy benefit managers (PBMs) to disclose negotiated drug rebates and discounts, reduce out-of-pocket costs for seniors who receive medication at a hospital-owned outpatient facility or doctor’s office, and extend funding for research into diabetes treatments.

“Our bipartisan legislation…will lower costs by giving patients the health care price information they need to make the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Regulations
Why One Startup CEO Is Excited About the White House’s New AI Czar Role
ASCs prepare for the Trump administration: 5 notes
Telehealth survives in federal spending plan, but fight for longer extension continues
Congress Passes Extension to Key Telehealth Payment Policies
6 key health policy areas to watch in the new year

Share This Article